Scinai to connect with investors, showcase its innovative i&i pipeline and its boutique cgmp biologics cdmo during bio-europe spring 2025

Jerusalem , march 17, 2025 /prnewswire/ -- scinai immunotherapeutics ltd. (nasdaq: scni), a biopharmaceutical company specializing in inflammation and immunology (i&i) biological products and in providing cdmo services through its scinai bioservices unit, today announced that it will be meeting with investors, showcasing its innovative i&i product pipeline in partnership meetings and exhibiting its cdmo boutique services at the bio-europe spring 2025 conference, taking place march 17-19 in milan, italy.
CDMO Ratings Summary
CDMO Quant Ranking